Epicriptine
From Wikipedia, the free encyclopedia
Main article: Dihydroergocryptine
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration |
Oral |
ATC code | N04BC03 (WHO) (alpha/beta) |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | beta-Dihydroergocryptine |
CAS Number | 19467-62-0 |
PubChem (CID) | 3084313 |
ChemSpider | 2341400 |
UNII | 5M64643B5U |
ChEBI | CHEBI:59925 |
ChEMBL | CHEMBL1378681 |
ECHA InfoCard | 100.039.157 |
Chemical and physical data | |
Formula | C32H43N5O5 |
Molar mass | 577.715 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Epicriptine or beta-dihydroergocryptine is a dopamine agonist of the ergoline class. It constitutes one third of the mixture known as dihydroergocryptine, the other two thirds consisting of alpha-dihydroergocryptine. The alpha differs from the beta form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid isoleucine is replaced by leucine.[1]
References[edit]
- ^ Steinhilber, D; Schubert-Zsilavecz, M; Roth, HJ (2005). Medizinische Chemie (in German). Stuttgart: Deutscher Apotheker Verlag. p. 142. ISBN 3-7692-3483-9.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |